Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TRANSITION THERAPEUTICS INC. T.TTH

"Transition Therapeutics Inc is a product-focused biopharmaceutical company. The Company is engaged in developing therapeutics for disease indications with markets. Its technologies are focused on the treatment of Alzheimer's disease and diabetes."


TSX:TTH - Post by User

Post by deninsaskon Nov 20, 2007 3:42pm
353 Views
Post# 13838823

How NOT to Run Clinical Trials 101.......

How NOT to Run Clinical Trials 101....... See Neurochem.......the Company that is The TextBook Example of How NOT to Run Clinical Trials 101. Bellini's Neurochem had NO Pre-Clinical evidence of Efficacy related to the Mechanism of Action that could be acheived in Humans for their ( Spring 2007) FAILED DRUG 'Alzhemed' and carried the story right through Phaselll's. Steam Rolled it all the way juggling the Statistical Data and Omitting Efficacy related Drop-outs from the Data and Pizzing Off the FDA in the process. Plain and Simple their FAILED DRUG ALZHEMED did NOT reach the Brain.........Never did.......Never will. AZD-103 Does.....check it out.
Bullboard Posts